載入...
Tumor-intrinsic and -extrinsic determinants of response to blinatumomab in adults with B-ALL
Blinatumomab, a bispecific antibody that directs CD3(+) T cells to CD19(+) tumor cells, shows variable efficacy in B-progenitor acute lymphoblastic leukemia (B-ALL). To determine tumor-intrinsic and -extrinsic determinants of response, we studied 44 adults with relapsed or refractory B-ALL (includin...
Na minha lista:
| 發表在: | Blood |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
American Society of Hematology
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7845009/ https://ncbi.nlm.nih.gov/pubmed/32881995 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood.2020006287 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|